| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BELLEROPHON THERAPEUTICS INC | 154,290 | 80,000 | 0.00% | ||
| 2 | KALVISTA PHARMACEUTICALS INC | 11,483 | 81,000 | 0.00% | ||
| 3 | PARNELL PHARMACEUTICALS HOLDINGS LTD | 147,458 | 102,000 | 0.00% | ||
| 4 | GALENA BIOPHARMA INCORPORATED COM NEW | 79,663 | 154,000 | 0.00% | Call | |
| 5 | WINDTREE THERAPEUTICS INC | 178,570 | 223,000 | 0.00% | Call | |
| 6 | MAST THERAPEUTICS INC COM | 2,969,381 | 258,000 | 0.00% | Call | |
| 7 | EASTERLY ACQUISITION CORP | 761,707 | 267,000 | 0.00% | Call | |
| 8 | MARRIOTT VACATIONS WORLDWIDE C COM | 3,156 | 268,000 | 0.00% | ||
| 9 | RLJ ENTMT INC | 200,000 | 320,000 | 0.00% | Call | |
| 10 | GEVO INC | 97,040 | 336,000 | 0.00% | Call | |
| 11 | Enservco Corp | 658,706 | 369,000 | 0.00% | ||
| 12 | LINCOLN EDL SVCS CORP | 195,644 | 376,000 | 0.00% | ||
| 13 | VASCULAR BIOGENICS LTD | 83,333 | 404,000 | 0.00% | Call | |
| 14 | CST BRANDS INC | 10,152 | 489,000 | 0.00% | ||
| 15 | Tracon Pharmaceuticals Inc | 100,000 | 490,000 | 0.00% | ||
| 16 | BOULEVARD ACQUISITION | 945,134 | 501,000 | 0.00% | Call | |
| 17 | AEGLEA BIOTHERAPEUTICS INC | 119,707 | 521,000 | 0.00% | ||
| 18 | INNOCOLL HLDGS PLC | 837,626 | 578,000 | 0.00% | ||
| 19 | WINDTREE THERAPEUTICS INC | 464,769 | 581,000 | 0.00% | ||
| 20 | BIOLINERX LTD | 642,421 | 591,000 | 0.00% | ||
| 21 | QUALYS INC | 18,727 | 593,000 | 0.00% | ||
| 22 | ARES CAPITAL CORP | 38,448 | 634,000 | 0.01% | ||
| 23 | ACHAOGEN INC COM | 50,000 | 651,000 | 0.01% | ||
| 24 | TURTLE BEACH CORP COM | 500,000 | 655,000 | 0.01% | ||
| 25 | TOPBUILD CORP | 18,625 | 663,000 | 0.01% | ||
| 26 | E L F BEAUTY INC | 24,000 | 695,000 | 0.01% | ||
| 27 | LANDCADIA HLDGS INC | 1,000,000 | 700,000 | 0.01% | Call | |
| 28 | BIOAMBER INC | 135,648 | 746,000 | 0.01% | Call | |
| 29 | PALATIN TECHNOLOGIES INC COM | 1,538,462 | 777,000 | 0.01% | Call | |
| 30 | GREENHILL & CO INC COM | 28,082 | 778,000 | 0.01% | ||
| 31 | Catabasis Pharmaceuticals Inc | 223,885 | 808,000 | 0.01% | ||
| 32 | INVUITY INC | 148,800 | 856,000 | 0.01% | ||
| 33 | NEOVASC INC | 513,383 | 888,000 | 0.01% | ||
| 34 | IMMUNE DESIGN CORP | 167,493 | 921,000 | 0.01% | ||
| 35 | GENOCEA BIOSCIENCES INC | 225,569 | 929,000 | 0.01% | ||
| 36 | DOUBLE EAGLE ACQUISITION COR | 2,000,000 | 940,000 | 0.01% | Call | |
| 37 | ARGOS THERAPEUTICS INC | 200,000 | 980,000 | 0.01% | Call | |
| 38 | FLEETCOR TECHNOLOGIES INC | 7,232 | 1,023,000 | 0.01% | ||
| 39 | VTV THERAPEUTICS INC | 213,200 | 1,030,000 | 0.01% | ||
| 40 | CIDARA THERAPEUTICS INC | 100,000 | 1,040,000 | 0.01% | ||
| 41 | ALIMERA SCIENCES INC | 1,013,892 | 1,095,000 | 0.01% | ||
| 42 | QUANTENNA COMMUNICATIONS INC COM | 61,126 | 1,108,000 | 0.01% | ||
| 43 | FULGENT GENETICS INC | 102,185 | 1,182,000 | 0.01% | ||
| 44 | RADIANT LOGISTICS INC | 316,168 | 1,233,000 | 0.01% | ||
| 45 | MYOVANT SCIENCES LTD | 100,404 | 1,249,000 | 0.01% | ||
| 46 | ARDMORE SHIPPING CORP COM | 176,678 | 1,307,000 | 0.01% | ||
| 47 | LA QUINTA HLDGS INC COM | 93,842 | 1,333,000 | 0.01% | ||
| 48 | CONTRAFECT CORP COM | 783,637 | 1,371,000 | 0.01% | ||
| 49 | SYROS PHARMACEUTICALS INC | 113,543 | 1,381,000 | 0.01% | ||
| 50 | AVINGER INC | 380,209 | 1,407,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001453072-17-000025, filed 2017.02.14), New Holdings filing (0001164691-18-000133, filed 2018.08.20), New Holdings filing (0001453072-18-000072, filed 2018.02.20), New Holdings filing (0001164691-17-000153, filed 2017.08.17), New Holdings filing (0001164691-17-000124, filed 2017.07.13). and New Holdings filing (0001164691-17-000114, filed 2017.05.17).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
